Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.
about
A Novel Dimeric Inhibitor Targeting Beta2GPI in Beta2GPI/Antibody Complexes Implicated in Antiphospholipid SyndromeOxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approachesIndications for a protective function of beta2-glycoprotein I in thrombotic thrombocytopenic purpura.Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model.Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I.Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome.Autoantibodies directed against domain I of beta2-glycoprotein I.Variability in exposure of epitope G40-R43 of domain i in commercial anti-beta2-glycoprotein I IgG ELISAs.An A1-A1 mutant with improved binding and inhibition of β2GPI/antibody complexes in antiphospholipid syndrome.Anti-β2-glycoprotein I paratopes and β2-glycoprotein I epitopes characterization using random peptide libraries.Are posttranslational modifications of β2-glycoprotein I markers for thrombotic risk? Are they triggers of autoimmunity?"New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndromeTreatment of the antiphospholipid syndrome.Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome.Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer's diseaseInsights into the pathophysiology of the antiphospholipid syndrome provided by atomic force microscopy.The Fifth Domain of Beta 2 Glycoprotein I Protects from Natural IgM Mediated Cardiac Ischaemia Reperfusion InjuryMeasuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.Significance of K(L/V)WX(I/L/V)P Epitope of the B2Gpi in Its (Patho)Physiologic Function.Small β2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury.Human β2-glycoprotein I attenuates mouse intestinal ischemia/reperfusion induced injury and inflammationPathophysiological mechanisms in antiphospholipid syndromeThe antiphospholipid syndrome: still an enigmaGram Negative Bacterial Inflammation Ameliorated by the Plasma Protein Beta 2-Glycoprotein I.Optimization of unnicked β2-glycoprotein I and high avidity anti-β2-glycoprotein I antibodies isolation.Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment.β(2) -Glycoprotein I: evolution, structure and function.Pathogenesis of antiphospholipid syndrome: understanding the antibodies.Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I.Guidelines on the investigation and management of antiphospholipid syndrome.Recent developments in our understanding of the antiphospholipid syndrome.Obstetric and vascular APS: same autoantibodies but different diseases?Antibodies against domain I of β2-glycoprotein I: the one and only?Anti-β2-glycoprotein I antibodies.Antiphospholipid antibodies mediate autoimmunity against dying cells.The current standing of diagnosis of antiphospholipid syndrome associated with systemic lupus erythematosus.The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity.New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glycoprotein-I antibodies.
P2860
Q27666379-91A08DFD-D73D-4F84-A399-42A93183486FQ28075691-D9FFC035-51B6-4C3C-B81D-2C70ED86103DQ33402759-10A907E8-50DA-4298-8FAC-727F14E9DD4BQ33403225-9A392EA5-3BCA-427D-B01F-F250D6018DC4Q33796355-26CA0BE1-0587-476B-A882-3B8E9561DA6CQ34069117-B3C6A1C6-1B79-4E6D-ADBC-4D51E89B05CDQ34287356-F698AFA4-156F-48BA-810A-8DEC4390903BQ34467454-5378C21E-6685-4C8D-A1BB-C7FF6DCCA243Q34949493-FF26EF88-2278-4071-99AA-C2DBB39E76C9Q35152055-3C9EE306-BD29-4107-9479-45010033D1A3Q35167094-7E7FCB19-6671-43EA-B4D8-05F676AC2B35Q35224238-06556EEB-B5EC-4B96-9E1C-9C50BF04ACA7Q35250419-844C6E0A-7835-4043-9B98-BC672EFD44A6Q35308972-3A826E28-FD42-4169-B2A0-2CE3D0B01CA3Q35419865-E47EFF35-ADE1-4374-9E99-CCE50ED4BD43Q35584256-72D94BA7-3374-461F-9524-8F8E4A1356C6Q35812498-D652752C-731A-4805-88E9-51DA4A4A77E8Q35927360-7B9DC541-A6D7-4897-B531-BA668CF95910Q35974974-897BAA69-2202-4CA8-BBDC-E9682EA6EE16Q36037794-DA6FC3F7-EB30-4FB5-8219-2523CE3C136DQ36147646-6B81F1B7-CF0B-47B5-AD68-41591799C7D2Q36374030-DC0F0E15-6E6A-4470-9D27-992A19102CC5Q36590359-328F7AED-4E98-41F2-B0AA-7E4FB2CC7EEDQ36671159-B74A5F62-EB1A-4CBA-951C-46EC1FF1894CQ36928593-9B67199E-A999-4BA9-B135-5523CCED7F0FQ37285373-8FEC9B21-32E8-4366-98E4-7C94535BE201Q37704570-DCD86D6F-6A44-4572-BEED-C9B689298C12Q37842673-BE9E4C22-0E80-4F52-A1D9-4DFD1FFD1A4AQ37871051-2AC210D1-B045-4C3E-B4DE-C4C288987503Q37873720-B094CB26-4CE4-4F77-B032-A12CC4DCFB57Q37903952-9BE230AD-8394-4525-BA4E-C66E4A2F51C2Q37982121-08BDA10D-696D-4831-A83E-473EE69F0329Q37991066-41F46996-17B0-43E5-9D36-D11B54F52D8BQ38013583-E2A217D9-3ECE-4BB3-A678-5CDBFA1F115FQ38013590-FB819D9B-AE7F-403E-8922-CE187E6CAA29Q38108396-14891742-E2BD-4866-BF66-42BF61D7C812Q38109906-8237AF16-2D20-4621-B29C-D5904DD8347AQ38125246-98180817-D224-4EEC-A077-063C6EC1D7E1Q38158240-4F390565-448C-4FD6-A8A6-73654022A135Q38175886-7833FACF-98D3-4235-AFBD-C95AD036997E
P2860
Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Beta2-glycoprotein I can exist ...... the antiphospholipid syndrome.
@ast
Beta2-glycoprotein I can exist ...... the antiphospholipid syndrome.
@en
Beta2-glycoprotein I can exist ...... the antiphospholipid syndrome.
@nl
type
label
Beta2-glycoprotein I can exist ...... the antiphospholipid syndrome.
@ast
Beta2-glycoprotein I can exist ...... the antiphospholipid syndrome.
@en
Beta2-glycoprotein I can exist ...... the antiphospholipid syndrome.
@nl
prefLabel
Beta2-glycoprotein I can exist ...... the antiphospholipid syndrome.
@ast
Beta2-glycoprotein I can exist ...... the antiphospholipid syndrome.
@en
Beta2-glycoprotein I can exist ...... the antiphospholipid syndrome.
@nl
P2093
P50
P1433
P1476
Beta2-glycoprotein I can exist ...... the antiphospholipid syndrome
@en
P2093
Cetin Agar
Gwendolyn M A van Os
J Arnoud Marquart
Matthias Mörgelin
Philip G de Groot
Ronald H W M Derksen
P304
P356
10.1182/BLOOD-2009-12-260976
P407
P577
2010-05-12T00:00:00Z